NOUVELLES CLINIQUES NIMOISES

NOUVELLES CLINIQUES NIMOISES

SIREN 808690200

Active

What the register says about NOUVELLES CLINIQUES NIMOISES

NOUVELLES CLINIQUES NIMOISES is registered under SIREN number 808690200. Its registered office is located at 3 Rue Jean Bouin, 30000 Nîmes. The company was founded on 01/12/2014. It declares that it operates in the Activités hospitalières sector. It is currently listed as active in the national business register.

BODACC has published 26 notices concerning it, the most recent dated 03/09/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

Identity : NOUVELLES CLINIQUES NIMOISES

NOUVELLES CLINIQUES NIMOISES

SIREN
808690200
Head office SIRET
80869020000023
Legal form
SAS (société par actions simplifiée)
NAF code
86.10Z · Activités hospitalières
Address
3 Rue Jean Bouin, 30000 Nîmes
Creation date
12/01/2014
Category
GE
Status
Active
VAT
FR23808690200
Filing
09/03/2026
Closing
12/31/2025

Recent notices (26)

All legal notices

Web presence : NOUVELLES CLINIQUES NIMOISES

The company's official website, its networks and online contact details.

Web presence : NOUVELLES CLINIQUES NIMOISES

Recent notices : NOUVELLES CLINIQUES NIMOISES

The BODACC notices published for this company.

Relations : NOUVELLES CLINIQUES NIMOISES

The relationship graph: linked notices, people and companies.

Public contracts : NOUVELLES CLINIQUES NIMOISES

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : NOUVELLES CLINIQUES NIMOISES

Frequently asked questions and the company's filing history.

Frequently asked questions : NOUVELLES CLINIQUES NIMOISES

Deposit filing history

10 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 12/31/2025.